AU5321796A - Novel piperazine derivatives as type il-1 receptor antagonists - Google Patents

Novel piperazine derivatives as type il-1 receptor antagonists

Info

Publication number
AU5321796A
AU5321796A AU53217/96A AU5321796A AU5321796A AU 5321796 A AU5321796 A AU 5321796A AU 53217/96 A AU53217/96 A AU 53217/96A AU 5321796 A AU5321796 A AU 5321796A AU 5321796 A AU5321796 A AU 5321796A
Authority
AU
Australia
Prior art keywords
type
receptor antagonists
piperazine derivatives
novel piperazine
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53217/96A
Inventor
Philippe R Bovy
Gary Alan Flynn
Ellen M Leahy
Rajeshavari D Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymax Technologies NV
Aventis Pharmaceuticals Inc
Original Assignee
Affymax Technologies NV
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymax Technologies NV, Hoechst Marion Roussel Inc filed Critical Affymax Technologies NV
Publication of AU5321796A publication Critical patent/AU5321796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/545IL-1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53217/96A 1995-03-23 1996-03-22 Novel piperazine derivatives as type il-1 receptor antagonists Abandoned AU5321796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US409375 1989-09-19
US40937595A 1995-03-23 1995-03-23
PCT/US1996/003955 WO1996029088A1 (en) 1995-03-23 1996-03-22 Novel piperazine derivatives as type il-1 receptor antagonists

Publications (1)

Publication Number Publication Date
AU5321796A true AU5321796A (en) 1996-10-08

Family

ID=23620213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53217/96A Abandoned AU5321796A (en) 1995-03-23 1996-03-22 Novel piperazine derivatives as type il-1 receptor antagonists

Country Status (2)

Country Link
AU (1) AU5321796A (en)
WO (1) WO1996029088A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140011728A1 (en) * 2011-02-15 2014-01-09 Novo Nordisk A/S Long-acting il-1 receptor antagonists
WO2016022465A1 (en) 2014-08-04 2016-02-11 Drexel University Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
EP0489690A1 (en) * 1990-12-05 1992-06-10 Ciba-Geigy Ag Substituted N-Benzoyl-N'-(2-phenylethyl)-piperazines
EP0524146A1 (en) * 1991-07-19 1993-01-20 Ciba-Geigy Ag Aminosubstituted Piperazinederivatives
US5384319A (en) * 1993-01-06 1995-01-24 Ciba-Geigy Corporation Aminoalkylphenyl compounds
US5380726A (en) * 1993-01-15 1995-01-10 Ciba-Geigy Corporation Substituted dialkylthio ethers
US5462939A (en) * 1993-05-07 1995-10-31 Sterling Winthrop Inc. Peptidic ketones as interleukin-1β-converting enzyme inhibitors

Also Published As

Publication number Publication date
WO1996029088A1 (en) 1996-09-26

Similar Documents

Publication Publication Date Title
AU5417296A (en) Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
AU696241B2 (en) Dihydropyridine NPY antagonists: piperazine derivatives
AU7131196A (en) Pyrimidine derivatives as 5ht2c-receptor antagonists
AU7692996A (en) Receptor antagonists
AU1765695A (en) Non-peptidyl tachykinin receptor antagonists
AU4396193A (en) 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
ZA964101B (en) Piperazine derivatives
AU4620397A (en) Piperazine derivatives
AU1345697A (en) Novel integrin receptor antagonists
AU5440996A (en) 2-acylaminopropanamides as tachykinin receptor antagonists
AU5333596A (en) 3-benzylamino-2-phenylpiperidines as neurokinin antagonists
AU2143295A (en) Neurokinin receptor antagonists
AU2697897A (en) Indole derivatives useful as endothelin receptor antagonists
AU6229696A (en) Novel heteroaromatic piperazines for use as drugs
AUPO735997A0 (en) Piperazine derivatives
AU5520298A (en) Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
AU6856796A (en) Des-arg9-bk antagonists
AU2314195A (en) Benzofuran derivatives as d4 receptor antagonists
GB9514901D0 (en) Piperazine derivatives
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1535699A (en) Novel receptors opg-2
AU6961796A (en) Improved interleukin-6 receptor antagonist
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU4991797A (en) Piperazino derivatives as neurokinin antagonists
AUPO863197A0 (en) Novel derivatives